MD862G2 - Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei - Google Patents

Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei

Info

Publication number
MD862G2
MD862G2 MD97-0168A MD970168A MD862G2 MD 862 G2 MD862 G2 MD 862G2 MD 970168 A MD970168 A MD 970168A MD 862 G2 MD862 G2 MD 862G2
Authority
MD
Moldova
Prior art keywords
dislipidemy
remedy
atherosclerosis treatment
pectine
increasing
Prior art date
Application number
MD97-0168A
Other languages
English (en)
Russian (ru)
Other versions
MD862F1 (ro
Inventor
Виктория ИВАНОВ
Надежда КРАСНОВА
Original Assignee
Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова filed Critical Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority to MD97-0168A priority Critical patent/MD862G2/ro
Publication of MD862F1 publication Critical patent/MD862F1/ro
Publication of MD862G2 publication Critical patent/MD862G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special, la cardiologie.Esenţa invenţiei constă în aceea că remediul pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei pe bază de polizaharide include pectină cu un grad de eterificare mai înalt de 70%, cu efect hipocolesterolemic, ce conţine cationi de calciu în cantitate de 300-500 mg-echiv./kg, în special pectină de măr.Rezultatul tehnic al invenţiei constă în creşterea proprietăţilor hipocolesterolemice cu reducerea trigliceridelor şi majorarea nivelului de C-HDL.
MD97-0168A 1997-06-23 1997-06-23 Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei MD862G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0168A MD862G2 (ro) 1997-06-23 1997-06-23 Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0168A MD862G2 (ro) 1997-06-23 1997-06-23 Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei

Publications (2)

Publication Number Publication Date
MD862F1 MD862F1 (ro) 1997-10-31
MD862G2 true MD862G2 (ro) 1998-07-31

Family

ID=19739022

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0168A MD862G2 (ro) 1997-06-23 1997-06-23 Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei

Country Status (1)

Country Link
MD (1) MD862G2 (ro)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.S. Truswell. " Dietary Fibre and Plasma Lipids: Potential for Prevention and Treatment of Hyperlipidaemias.Dietary Fibre-A component of food.1993.p.295-348. *
Cs. gastroenterologie, V.37,N1, E. Ginter, R. Kohn, A. Malovicova et al. " Zavislost. Hipolipemickeno ucinki pectinov na ich chemickom Zlozeni", p.37-46. *

Also Published As

Publication number Publication date
MD862F1 (ro) 1997-10-31

Similar Documents

Publication Publication Date Title
HUT68689A (en) Alpha-heteroaryloxymethyl-ketones as interleukin-1-beta converting enzyme inhibitors, pharmaceutical compositions containing them, process for producing them and the compositions
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
MXPA05001096A (es) Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
EP0659769A3 (en) Means to promote the proliferation of Bifidobacterium.
YU15299A (sh) Farmaceutski sastavi
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
SG145698A1 (en) Methods of treating or preventing autoimmune diseases with 2,4- pyrimidinediamine compounds
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
BG105556A (en) New esters derived from substituted phenyl-cyclohexyl compounds
IL110943A0 (en) Compositions for the treatment of skin disorders
HUP9700926A3 (en) Vitamine d3 analogues, process for producing them and pharmaceutial compositions containing the same
GB9300048D0 (en) Endothelin converting enzyme inhibitors
HK1033096A1 (en) Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders
MXPA04002565A (es) Combinacion de un inhibidor de il-1/18 con un inhibidor de tnf para el tratamiento de inflamacion.
IL107736A0 (en) Triphostins and pharmaceutical compositions containing them
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
EP1275379A3 (en) Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
EP0858262A4 (en) THROMBIN INHIBITORS
MD862G2 (ro) Remediu pentru tratamentul şi profilaxia dislipidemiilor şi aterosclerozei
HK1029099A1 (en) 2-amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
NZ525536A (en) Treatment of arthritis and other similar conditions
AU6849198A (en) Neurotrypsin

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20170623

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees